These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25434346)

  • 1. [Invasive mould disease in haematological patients].
    Ruiz-Camps I; Jarque I
    Rev Iberoam Micol; 2014; 31(4):249-54. PubMed ID: 25434346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Invasive fungal infection in haematology patients].
    Vallejo Llamas JC; Ruiz-Camps I
    Enferm Infecc Microbiol Clin; 2012 Nov; 30(9):572-9. PubMed ID: 23079614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [State of the art in invasive diseases by filamentous fungi].
    Pemán J; Quindós G
    Rev Iberoam Micol; 2014; 31(4):213-8. PubMed ID: 25449676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential of anidulafungin in hematological patients].
    Vázquez López L; Ruiz Camps I
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():44-50. PubMed ID: 19572434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of anidulafungin in solid organ transplant recipients].
    Aguado JM; Ayats J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():29-34. PubMed ID: 19572432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD; Kourbeti IS; Mylonakis E
    Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
    Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
    Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.
    Blyth CC; Gilroy NM; Guy SD; Chambers ST; Cheong EY; Gottlieb T; McGuinness SL; Thursky KA
    Intern Med J; 2014 Dec; 44(12b):1333-49. PubMed ID: 25482744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive aspergillosis in cancer patients.
    Bow EJ
    Oncology (Williston Park); 2001 Aug; 15(8):1035-9; discussion 1040, 1042-4, 1047. PubMed ID: 11548975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].
    Gurguí M; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():1-6. PubMed ID: 19572428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants].
    Quindós G
    Rev Iberoam Micol; 2011; 28(3):110-9. PubMed ID: 21700230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the epidemiological landscape of invasive mould infections and disease.
    Lass-Flörl C; Cuenca-Estrella M
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i5-i11. PubMed ID: 28355462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Invasive fungal infection in solid organ transplant].
    Gavaldà J; Meije Y; Len Ó; Pahissa A
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):645-53. PubMed ID: 23127517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aspergillus galactomannan detection in allogenic hematopoietic cell transplantation].
    Rovira Tarrats M; Puig de la Bellacasa J
    Rev Iberoam Micol; 2003 Sep; 20(3):111-5. PubMed ID: 15456367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of invasive fungal infection.
    Castón-Osorio JJ; Rivero A; Torre-Cisneros J
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S103-9. PubMed ID: 19013332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
    Klingspor L; Saaedi B; Ljungman P; Szakos A
    Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive mould infections in the ICU setting: complexities and solutions.
    Bassetti M; Bouza E
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Invasive fungal disease due to Scedosporium, Fusarium and mucorales].
    Pemán J; Salavert M
    Rev Iberoam Micol; 2014; 31(4):242-8. PubMed ID: 25442383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspofungin for treatment of invasive aspergillus infections.
    Heinz WJ; Einsele H
    Mycoses; 2008; 51 Suppl 1():47-57. PubMed ID: 18471161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis for invasive mycoses in high risk patients.
    Ullmann AJ; Cornely OA
    Curr Opin Infect Dis; 2006 Dec; 19(6):571-6. PubMed ID: 17075333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.